AXS 2X PFE Bull Daily ETF
PFEL
NASDAQ Global Market- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Address
- United States of America
- IPO Date
- Jul 13, 2022
- Similar Companies
- Business
- AXS 2X PFE Bull Daily ETF (PFEL) is an actively managed exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times (200%) the daily performance of the common shares of Pfizer Inc. (PFE). The fund achieves its objective through financial instruments, including swap agreements that provide leveraged exposure to PFE's daily price movement, while maintaining at least 80% of its assets in such instruments under normal market conditions; it does not pursue its target over periods longer than a single trading day. Launched on July 14, 2022, and listed on NASDAQ, PFEL operates within the leveraged equities segment, targeting sophisticated traders and investors seeking amplified short-term bullish exposure to Pfizer stock, a leading pharmaceutical company focused on innovative medicines and vaccines. PFEL forms part of the broader suite of single-stock leveraged ETFs offered by its investment adviser, AXS Investments LLC, which manages a range of alternative investment strategies including ETFs and mutual funds exposed to real assets, ESG themes, next-generation economies, and venture capital returns. Geographically, the fund focuses on U.S.-listed securities with primary operations tied to Pfizer's global presence across North America, Europe, and emerging markets. AXS Investments, founded in 2019, is headquartered at 181 Westchester Avenue, Suite 402, Port Chester, New York, and serves as adviser under the Investment Managers Series Trust II statutory trust structure. In recent developments, AXS Investments expanded its single-stock ETF offerings in July 2022 by launching PFEL alongside its bear counterpart (PFES) and similar products for stocks like Nike, as part of the first U.S. suite of such leveraged bull and bear funds approved by regulators. The firm has pursued strategic growth through acquisitions, including the AXS Change Finance ESG ETF (CHGX) in March 2022, and continues to innovate with unconventional strategies amid ongoing SEC approvals for additional single-stock ETFs targeting companies like ConocoPhillips and Salesforce. No major funding rounds, partnerships, or operational reorganizations specific to PFEL have been reported in the last 1-2 years, with the fund maintaining steady assets under management of approximately $694 thousand and low trading volume as of late 2025.